Listen

Hurry, Time is Wasting: The Pharmacy Workforce and the Cost-Effectiveness and Safety of Ready to Administer Products

This educational activity will review the evidence for the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method, present the latest study on pharmacy-related costs associated with IV push products, and discuss real-world aspects of transitioning from traditional to RTA products. Faculty will discuss barriers, challenges, and the data and information needed to build an institution-specific value proposition to persuade decision makers to adopt or expand use of RTA prefilled syringes. Participants will be guided by faculty to begin to develop their own specific plans for adoption or expanded use of RTA prefilled syringes at their practice sites.

Tuesday, Dec. 9
11:30 a.m. - 1 p.m. PT (12:30 - 2 p.m. ET)

Symposium Location: Islander Ballroom H, Lower Level, Mandalay Bay North Convention Center

Come early! Seating is limited and provided on a first-come, first-served basis.
Lunch is provided for this activity.

Can't make it to Las Vegas? Tune into the Free Live Webinar Broadcast.
Registration is required for the webinar.

Webinar Registration

Speakers

John Hertig, PharmD, MS, CPPS, FASHP, FFIP Activity Chair
Founder
Hertig Healthcare Advising, LLC
Adjunct Assistant Professor
Purdue University
Indianapolis, Indiana

Dr. John Hertig is Founder of ‘Hertig Healthcare Advising’ and Adjunct Faculty at Purdue University (Indianapolis, USA). Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, and health policy topics. He serves as an Editor-in-Chief for the Journal of Medicine Access, and his extensive research program is designed to enhance the safety of the medication use process, while using evidence to inform patient advocacy efforts.

Dr. Hertig is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Treasurer for the Hospital Pharmacy Section, and as Past-President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP).

Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University (USA). He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University (USA). He is a Certified Professional in Patient Safety (CPPS), a Fellow of the American Society of Health System Pharmacists (FASHP), and a Fellow of the International Pharmaceutical Federation (FFIP).

Ryan Haumschild, PharmD, MS, MBA , CPEL
Vice President of Ambulatory Pharmacy
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Ryan Haumschild is an experienced Vice President of Pharmacy at Emory University overseeing profit & loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use across one of the nation’s largest academic integrated delivery networks. Ryan provides strategic direction within the health plan as it relates to infusion and specialty pharmacy services, and the expansion of clinical services through treatment pathway development. He has achieved the Certified Pharmacy Executive Leader (CPEL) designation from ASHP which represents the highest credential for an executive pharmacy leader by acknowledging unique expertise and provides national recognition of core competencies in professionalism, leading people, leading the pharmacy enterprise, and leading within and across complex integrated delivery networks. Ryan currently serves as an Editorial Board Member at the American Journal of Managed Care® (AJMC®), Board member for both the Institute of Safe Medication Practices (ISMP) and Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.

Target Audience

This activity was planned to meet the educational needs of pharmacists in leadership positions including pharmacy executives, managers and supervisors, front-line clinical pharmacists and those in product procurement roles who can identify specific opportunities for realizing benefit from the use of ready-to-administer (RTA) prefilled syringes.

Learning Objectives

Compare the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes versus traditional vial-and-syringe method.
Evaluate new evidence regarding the pharmacy costs associated with IV push products.
Identify specific data and actions needed to determine incorporating RTA prefilled syringes in healthcare facilities.

Agenda

11:30 a.m. – Welcome and Introductions
John Hertig
11:35 a.m. – Review of the Evidence: Safety and Cost-Effectiveness of RTA Prefilled Syringes
John Hertig
11:55 a.m. – Pharmacy Costs Associated with IV Push Products
All Faculty
12:15 p.m. – RTA: Real-World Barriers, Challenges and Success Stories
Ryan Haumschild
12:40 p.m. – Hot Topic Discussion
All Faculty
12:50 p.m. – Faculty Discussion, Questions and Answers
All Faculty

Accredited for CPE

ACPE #: 0204-0000-25-412-L04-P
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.